Form 4 filed by Venrock Healthcare Capital Partners III, L.P.
Venrock Healthcare Capital Partners III, L.P. filed this Form 4 on Lycia Therapeutics, Inc. with 9 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-27 22:38:10 UTC.
- Accession
- 0001231919-26-001503
- Filer
- CIK 1738048
- Filed
- 2026-10-27
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: Lycia Therapeutics, Inc. (CIK 1806540)
- Venrock Healthcare Capital Partners III, L.P. 10% owner
- VHCP Co-Investment Holdings III, LLC 10% owner
- VHCP Management III, LLC 10% owner
- Venrock Healthcare Capital Partners EG, L.P. 10% owner
- VHCP Management EG, LLC 10% owner
- Venrock Healthcare Capital Partners XP, L.P. 10% owner
- VHCP Management XP, LLC 10% owner
- Koh Bong Y 10% owner
- Shah Nimish P 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-23 | P bought | +24,560 | $25.68 | 24,560 | I By Funds |
| Common Stock | 2026-10-23 | P bought | +28,379 | $26.11 | 52,939 | I By Funds |
| Common Stock | 2026-10-26 | C converted | +4,779,793 | 4,832,732 | I By Funds | |
| Common Stock | 2026-10-26 | P bought | +1,944,444 | $18 | 6,777,176 | I By Funds |
| Common Stock | 2026-10-26 | P bought | +8,261 | $26.97 | 6,785,437 | I By Funds |
| Common Stock | 2026-10-27 | P bought | +8,729 | $25.84 | 6,794,166 | I By Funds |
| Common Stock | 2026-10-27 | P bought | +31,067 | $26.84 | 6,825,233 | I By Funds |
| Series C Preferred Stock derivative | 2026-10-26 | C converted | -17,142,578 | $0 | 0 | I By Funds |
| Series D Preferred Stock derivative | 2026-10-26 | C converted | -4,408,091 | $0 | 0 | I By Funds |